Abstract
Hyoscine and drotaverine effectiveness was compared for the purposes of achieving optimum distension following insufflation in CT colonography. The in vitro effects of hyoscine and drotaverine on tone and contractility of SM preparations isolated from different areas of human colon were studied by isometric registration of contractile activity. Both medications have a relaxing effect on SM preparations and inhibit their spontaneous contractions. The drotaverine-induced effects were reliably more marked than the hyoscine-induced ones. CT colonography was performed in 70 patients who were injected with equal doses of either hyoscine (n=32) or drotaverine (n=38). The degree of drug-induced distension in both groups was determined by measuring the lumen of the colon on a 2D reconstruction. In most colon areas the width of the distended lumen was greater in the drotaverine-treated patients. We concluded that drotaverine can be used as a means to facilitate colonic distension.
Similar content being viewed by others
References
Laghi A., Virtual colonoscopy: clinical application, Eur. Radiol., 2005, 15Suppl 4, D138–141
Deshpande K.K., Summers R.M., Van Uitert R.L., Franaszek M., Brown L., Dwyer A.J., et al., Quality assessment for CT colonography: validation of automated measurement of colonic distention and residual fluid, A.J.R., 2007, 189, 1457–1463
Taylor S.A., Halligan S., Goh V., Morley S., Bassett P., Atkin W., et al., Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter, Radiology, 2003, 229, 99–108
Levatter R., Rethinking the argument against glucagon for CT colonography, A.J.R., 2000, 174, 1787–1790
Morrin M.M., Farrell R.J., Keogan M.T., Kruskal J.B., Yam C.S., Raptopoulos V., CT colonography: colonic distention improved by dual positioning but not intravenous glucagon, Eur. Radiol., 2002, 12, 525–530
Rogalla P., Lembcke A., Rückert J.C., Hein E., Bollow M., Rogalla N.E., et al., Spasmolysis at CT colonography: butylscopolamine versus glucagon, Radiology, 2005, 236, 184–188
Power N., Pryor M., Martin A., Horrocks J., McLean A., Reznek R., Optimization of scanning parameters for CT colonography, Br. J. Radiol., 2002, 75, 401–408
Bruzzi J.F., Moss A.C., Brennan D.D., MacMathuna P., Fenlon H.M., Efficacy of IV Buscopan as a muscle relaxant in CT colonography, Eur. Radiol. 2003, 13, 2264–2270
Yee J., CT colonography: examination prerequisites, Abdom. Imaging., 2002, 27, 244–252
Tytgat G.N., Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain, Drugs, 2007, 67, 1343–1357
Khalif I.L., Quigley E.M., Makarchuk P.A., Golovenko O.V., Podmarenkova L.F., Dzhanaev Y.A., Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics). J Gastrointestin Liver Dis, 2009, 18, 17–22
Sirakov N.V., Velkova K.G., Nikolov R.R., Sirakov V.N., Improvement of visualization in computed tomographic colonography after mechanic air insufflations, Folia Medica, 2006, 48, 46–49
Gill R.C., Cote K.R., Bowes K.L., Kingma Y.J., Human colonic smooth muscle: electrical and contractile activity in vitro, Gut 1986, 27, 293–299
Rami A., Krieglstein J., Muscarinic-receptor antagonist scopolamine rescues hippocampal neurons from death induced by glutamate, Brain Res. 1998, 788, 323–328
Gómez A., Martos F., Bellido I., Marquez E., Garcia A., Pavia J., et al., Muscarinic receptor subtypes in human and rat colon smooth muscle, Biochem. Pharmacol. 1992, 43, 2413–2419
Preiksaitis H.G., Krysiak P.S., Chrones T., Rajgopal V., Laurier L.G., Pharmacological and molecular characterization of muscarinic receptor subtypes in human esophageal smooth muscle, J. Pharmacol. Exp. Ther. 2000, 295, 879–888
Stengel P.W., Yamada M., Wess J., Cohen M.L., M3-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea, Am. J. Physiol., 2002, 282, R1443–R1449
Matsui M., Motomura D., Fujikawa T., Jiang J., Takahashi S., Manabe T., et al., Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable, J. Neurosci. 2002, 22, 10627–10632
Wang J., Krysiak P.S., Laurier L.G., Sims S.M., Preiksaitis H.G., Human esophageal smooth muscle cells express muscarinic receptor subtypes M1 through M5, Am. J. Physiol., 2000, 279, G1059–G1069
Kerr P.M., Hillier K., Wallis R.M., Garland C.J., Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon, Br. J. Pharmacol. 1995, 115, 1518–1524
Mansfield K.J., Mitchelson F.J., Moore K.H., Burcher E., Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes, Eur. J. Pharmacol., 2003, 482, 101–109
Barocelli E., Ballabeni V., Chiavarini M., Caretta A., Molina E., Impicciatore M., Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine, Pharmacol. Res. 1995, 31, 43–48
Turiiski V.I., Krustev A.D., Sirakov V.N., Getova D.P., In vivo and in vitro study of the influence of anticholinesterase drug galantamine on motor I evacuative functions of rat gastrointestinal tract, Eur. J. Pharmacol., 2004, 498, 233–239
Hoting E., Reiss J., Schulz K.H., Papaverineffective in therapy of pruritus of atopic dermatitis, Z. Hautkr., 1990, 65, 725–729
Willenbucher R.F., Xie Y.N., Eysselein V.E., Snape Jr. W,R., Mechanisms of cAMP-mediated relaxation of distal circular muscle in rabbit colon, Am. J. Physiol. Gastrointest. Liver Physiol., 1992, 262, G159–G164
Lin CS., Lin G., Xin ZC., Lue TF., Expression, distribution and regulation of phosphodiesterase 5, Curr. Pharm., 2006, 12, 3439–3457
Rüegg J.C., Sparrow M.P., Mrwa U., Cyclic-AMP mediated relaxation of chemically skinned fibers of smooth muscle, Pflugers Arch., 1981, 390, 198–201
Kusakari Y., Hongo K., Kawai M., Konishi M., Kurihara S., Use of the Ca-shortening curve to estimate the myofilament responsiveness to Ca2+ in tetanized rat ventricular myocytes, J. Physiol. Sci., 2006, 56, 219–226
Takashi O., Masatoshi H., Hiroshi O., Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced?, Smooth Muscle Res. 2007, 43, 43–54
McConalogue K., Furness J.B., Gastrointestinal neurotransmitters, Bailliere’s Clin. Endocrinol. Metab., 1994, 8, 51–76
Shafik A., Origin of rectal electric waves: further study, Dis. Colon. Rectum., 1999, 42, 1626–1631
Langton P., Ward S.M., Carl A., Norell M.A., Sanders K.M., Spontaneous electrical activity of interstitial cells of Cajal isolated from canine proximal colon, Proc. Natl. Acad. Sci. USA, 1989, 86, 7280–7284
Shafik A., El-Sibai O., Role of the enteric nervous plexus in rectal motile activity: an experimental study, J. Invest. Surg. 2001, 14, 275–281
Tsugeno M., Huang S.M., Pang Y.W., Chowdhury J.U., Tomita T: Effects of phosphodiesterase inhibitors on spontaneus electical activity (slow waves) in the guinea pig gastric muscle, J. Physiol., 1995, 485, 493–502
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kristev, A.D., Sirakov, N.V., Getova, D.P. et al. Comparing hyoscine and drotaverine effects on colon in CT colonography. cent.eur.j.med 6, 234–242 (2011). https://doi.org/10.2478/s11536-010-0065-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11536-010-0065-y